来源：智通财经网 公开资料显示，5月24日，美妆博主"大嘴博士"郝宇发布检测报告，指出巨子生物旗下可复美"胶原 棒"产品中所含重组胶原蛋白实际含量仅为0.0177%，远低于其宣传标准，且关键氨基酸甘氨酸"未检 出"，质疑该产品涉嫌虚假宣传。巨子生物迅速否认，称产品合规，内部检测远超0.1%。6月1日，华熙 生物发文力挺郝宇。巨子生物则称收到了郝宇所用检测机构的"道歉声明"，指其"从未授权郝宇使用报 告"。此后，双方多次隔空交锋，直至6月23日，巨子生物发布声明，承认其"现有的质量标准、检测方 法和标签标识在某些方面已逐渐显现出其局限性"。 消息面上，华熙生物近日就此前备受关注的"支持郝宇博士"一事作出正式回应。华熙生物称，公司在接 到郝宇的求助后，已联合国家计量院等多家第三方检测机构对相关企业的相关产品展开检测，结果几十 份检测结果均显示，相关产品中的重组胶原蛋白添加量未达标。华熙生物表示，"已将数十份检测报告 提交国家药品监督管理局。" 巨子生物(02367)盘中重挫15%，截至发稿，跌11.8%，报54.2港元，成交额17.16亿港元。 ...

Core Viewpoint - The stock of Giant Bio (02367) experienced a significant decline of 15% during trading, with a current drop of 11.8%, trading at HKD 54.2, and a transaction volume of HKD 1.716 billion [1] Group 1: Company Response and Actions - Huaxi Bio has officially responded to the controversy surrounding Dr. Hao Yu, stating that it has collaborated with multiple third-party testing organizations to assess related products, revealing that the recombinant collagen protein content did not meet standards in several test results [1] - Huaxi Bio has submitted dozens of test reports to the National Medical Products Administration [1] - Giant Bio quickly denied the allegations, asserting that its product complies with standards and that internal testing results exceed 0.1% [1] Group 2: Controversy and Public Reactions - On May 24, beauty blogger Dr. Hao Yu released a test report claiming that the actual recombinant collagen protein content in Giant Bio's "Collagen Stick" was only 0.0177%, significantly lower than advertised, and that the key amino acid glycine was "not detected," raising concerns of false advertising [1] - Following the initial claims, Giant Bio received an apology from the testing organization used by Dr. Hao Yu, stating that it had "never authorized Dr. Hao to use the report" [1] - On June 23, Giant Bio acknowledged that its "existing quality standards, testing methods, and labeling have gradually shown limitations in certain aspects" [1]

消息面上，华熙生物近日就此前备受关注的"支持郝宇博士"一事作出正式回应。华熙生物称，公司在接 到郝宇的求助后，已联合国家计量院等多家第三方检测机构对相关企业的相关产品展开检测，结果几十 份检测结果均显示，相关产品中的重组胶原蛋白添加量未达标。华熙生物表示，"已将数十份检测报告 提交国家药品监督管理局。" 公开资料显示，5月24日，美妆博主"大嘴博士"郝宇发布检测报告，指出巨子生物旗下可复美"胶原 棒"产品中所含重组胶原蛋白实际含量仅为0.0177%，远低于其宣传标准，且关键氨基酸甘氨酸"未检 出"，质疑该产品涉嫌虚假宣传。巨子生物迅速否认，称产品合规，内部检测远超0.1%。6月1日，华熙 生物发文力挺郝宇。巨子生物则称收到了郝宇所用检测机构的"道歉声明"，指其"从未授权郝宇使用报 告"。此后，双方多次隔空交锋，直至6月23日，巨子生物发布声明，承认其"现有的质量标准、检测方 法和标签标识在某些方面已逐渐显现出其局限性"。 巨子生物(02367)盘中重挫15%，截至发稿，跌11.8%，报54.2港元，成交额17.16亿港元。 ...